A new study revealed that eating the type of nuts daily may contribute to reducing the risk of colon cancer, thanks to its anti -inflammatory and cancer properties. The study was published in the “Cancer Prevention Research” journal (Cancer Prevention Research), and it is one of the first human clinical trials, which link the eating of nuts with positive health effects on the colon, especially through natural compounds known In the name of “Elagitanins”.
According to researchers from the College of Medicine at the University of Connecticut, the bacteria of the intestine converts these compounds to “Eurolithins”, especially “Eurolithin A”, which the study showed that it reduces the levels of proteins associated with colon cancer such as “Viminin”.
Using advanced imaging techniques, the team noted a noticeable decrease in the signs of inflammation inside the tissues of the colon breasts in patients who took the nuts regularly.
The study concluded that the nuts may be a simple and effective nutritional means to help prevent colon cancer, especially for those who have a healthy intestine microbium, with additional health benefits and small side risks.
The new study was based on a previous research conducted on the mice, led by Professor Massako Nakanishi, who first indicated that nuts can reduce the risk of cancer, which paved its results to conduct the first human clinical trial in this regard.
According to the American Disease Control and Prevention Centers, 141,902 new colon and rectum cancer were recorded in 2021, and 52,967 people died due to this disease in 2022.
The American Cancer Society estimates that this year 2025, there will be about 107,320 new colon cancer cases (54,510 in men and 52,810 in women) and about 46,950 new cases of rectal cancer.
